Abstract
The characteristic findings of intimal thickening and resulting steno-occlusion at the terminal portion of the internal carotid artery (ICA) along with pathological changes in neighboring arteries have been enumerated in the guidelines for the diagnosis of moyamoya disease [1, 2]. Fibrocellular thickening of the intima, an irregular disruption of the internal elastic lamina, and the attenuation of the media are the main findings [1, 3]. These findings have been observed not only in the carotid fork but also in cortical branches of the middle cerebral artery (MCA) [1, 3, 4]. In perforating arteries, microaneurysm formation and fragmented elastic lamina have been detected, and these are considered to be one of the reasons for intracerebral hemorrhage [1]. Sometimes, extracranial arteries such as superior temporal arteries (STA) and renal arteries have also been shown to be affected by the same stenotic changes, so that moyamoya disease can be considered to be a kind of systemic diseases [5].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kuroda S, Houkin K (2008) Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:1056–1066
Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226–1237
Achrol AS, Guzman R, Lee M et al (2009) Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus 26:E4
Takagi Y, Kikuta K, Nozaki K et al (2007) Histological features of middle cerebral arteries from patients treated for moyamoya disease. Neurol Med Chir (Tokyo) 47:1–4
Aoyagi M, Fukai N, Yamamoto M et al (1996) Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke 27:1750–1754
Soriano SG, Cowan DB, Proctor MR et al (2002) Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome. Neurosurgery 50:544–549
Fujimura M, Watanabe M, Narisawa A et al (2009) Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol [Epub ahead of print]
Yamamoto M, Aoyagi M, Fukai N et al (1999) Increase in prostaglandin E(2) production by interleukin-1beta in arterial smooth muscle cells derived from patients with moyamoya disease. Circ Res 85:912–918
Yamamoto M, Aoyagi M, Tajima S et al (1997) Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with Moyamoya disease. Stroke 28:1733–1738
Nanba R, Kuroda S, Ishikawa T et al (2004) Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke 35:2837–2842
Houkin K, Yoshimoto T, Abe H et al (1998) Role of basic fibroblast growth factor in the pathogenesis of moyamoya disease. Neurosurg Focus 5:e2
Noda A, Suzuki Y, Takayasu M et al (2000) Elevation of nitric oxide metabolites in the cerebrospinal fluid of patients with moyamoya disease. Acta Neurochir (Wien) 142:1275–1279
Aoyagi M, Fukai N, Matsushima Y et al (1993) Kinetics of 125I-PDGF binding and down-regulation of PDGF receptor in arterial smooth muscle cells derived from patients with moyamoya disease. J Cell Physiol 154:281–288
Yamamoto M, Aoyagi M, Fukai N et al (1998) Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya disease. Stroke 29:1188–1193
Takagi Y, Kikuta K, Nozaki K et al (2007) Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with moyamoya disease. Neurosurgery 60:338–345
Hojo M, Hoshimaru M, Miyamoto S et al (1998) Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg 89:623–629
Hoshimaru M, Takahashi JA, Kikuchi H et al (1991) Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg 75:267–270
Takagi Y, Kikuta K, Sadamasa N et al (2006) Caspase-3-dependent apoptosis in middle cerebral arteries in patients with moyamoya disease. Neurosurgery 59:894–900
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer
About this chapter
Cite this chapter
Takagi, Y. (2010). Vascular Smooth Muscle Cell-Related Molecules and Cells. In: Cho, BK., Tominaga, T. (eds) Moyamoya Disease Update. Springer, Tokyo. https://doi.org/10.1007/978-4-431-99703-0_11
Download citation
DOI: https://doi.org/10.1007/978-4-431-99703-0_11
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-99702-3
Online ISBN: 978-4-431-99703-0
eBook Packages: MedicineMedicine (R0)